The newest generation ofliquid biopsy testing for physicians
Longitudinal monitoring ofstudy participants
collaborations with industryleaders & major research centers
Complementary tests that support clinical decisions when monitoring patients before, during and after cancer treatment.
Learn More →
A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.
An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.
Events & Conferences
Visit Cynvenio at booth #S11 on Saturday, July 29th to learn more about the latest in ClearID Liquid Biopsy testing.